GlassScriptPrepare for your visit
Michael V Boland
Ophthalmology · Boston, MA · NPI 1023074143
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$80,629.84
in general payments reported to CMS, 2019-2025 · $2,627 in 2025
The $2,627 reported for 2025 was more than what 90% of Ophthalmology providers received nationally (typical 2025 total: $384).
Who reported paying
General payments only, top 6 by amount.
- Topcon Healthcare, INC. $34,105.82
- Carl Zeiss Meditec, INC. $31,229.58
- Abbvie INC. $10,078.14
- Janssen Research & Development, LLC $4,225.00
- Allergan, INC. $822.16
- Carl Zeiss Meditec USA, INC. $123.05
Drugs and devices associated with these payments
Cirrus Hd-Oct Forum Forum Glaucoma Workplace Humphrey Hfa Humphrey Field Analyzer (Hfa3) Clarus Visumax Iolmaster 700 Retina Workplace Quatera 700 Veracity Surgical Lumera 700
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Michael Boland listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/845/michael-v-boland